Skip to content

Pharminent

Primary Menu
  • Home
    • Pro Hub
Light/Dark Button
Hub
  • Home
  • Manufacturing
  • Cellares and Sonoma partner to automate cell therapy manufacturing
  • Manufacturing

Cellares and Sonoma partner to automate cell therapy manufacturing

Pharmaceutical Technology

Cellares and Sonoma Biotherapeutics have partnered to automate the manufacturing of the latter's SBT-77-7101 programme using the Cellares Cell Shuttle platform.

Gene Therapy Platform

Read full story

pharminent July 14, 2026 (Last updated: July 15, 2026)

Pharmaceutical Technology

Cellares and Sonoma Biotherapeutics have partnered to automate the manufacturing of the latter’s SBT-77-7101 programme using the Cellares Cell Shuttle platform.

Gene Therapy Platform

Read full story

Post navigation

Previous: Mahzi Lets Rare-Disease Families Invest in Its Gene Therapy
Next: FDA clears at-home start dose for Alzheimer’s drug Leqembi

Related Stories

  • Manufacturing

Sandoz plans ‘vast and vertically integrated’ supply chain to support 100-biosimilar vision

pharminent September 9, 2026
  • Manufacturing

US puts $125m into personalised RNA therapy production

pharminent September 2, 2026
  • Manufacturing

Multispecifics are transforming the CDMO development architecture

pharminent August 28, 2026
  • Home
  • Contact
© 2026 All rights reserved. | ReviewNews by AF themes.